Thyroid Cancer Epidemiology in Iran: a Time Trend Study

  • Safavi, Ali (Department of Otolaryngology, Head and Neck Surgery, Shahid Beheshti University of Medical Sciences) ;
  • Azizi, Fereidoun (Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences) ;
  • Jafari, Rozita (Department of Otolaryngology, Head and Neck Surgery, Shahid Beheshti University of Medical Sciences) ;
  • Chaibakhsh, Samira (Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences) ;
  • Safavi, Amir Ali (School of Medicine, Shahid Beheshti University of Medical Sciences)
  • Published : 2016.02.05


Background: Considering the rising incidence of thyroid cancer worldwide, the aim of our study was to investigate the temporal trends in the incidence of this cancer in a large population of Iranian patients. Materials and Methods: We used the Iran Cancer Data System (ICDS) Registry to assess the thyroid cancer trend from 2004 to 2010 with regard to different genders, age groups, and morphologies. To do this we analyzed the data of 10,913 new cases of thyroid cancer that occurred during these years. Results: The incidence rate (per one year) of thyroid cancer was 2.20 per 100,000 persons between 2004 and 2010 in Iran. Papillary thyroid cancer was the most common histology type, with an annual rate of 0.29 in Iran. The highest rate of prevalence in thyroid cancer was observed at the age of 45 years at the time of diagnosis. We found a female-to-male ratio of 2 in Iran. A significant decrease was detected in the trend of thyroid cancer in children <19y, which was not correlated to the trend of older patients. Conclusions: As expected, the trend of thyroid cancer increased over the 7 years, primarily contributed by papillary thyroid cancer. A rising pattern of incidence was seen in all the age groups except patients aged under 19 years.


Thyroid cancer;epidemiology;trend;papillary cancer;follicular cancer;cancer registry


  1. Aceves C, Anguiano B, Delgado G (2013). The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissues. Thyroid, 23, 938-46.
  2. Albores-Saavedra J, Henson DE, Glazer E, Schwartz AM (2007). Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr Pathol, 18, 1-7.
  3. American Cancer Society 2009, Cancer facts and figures 2008,
  4. Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS (2011). Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid, 21, 125-34.
  5. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C (2007). Extent of surgery affects survival for papillary thyroid cancer. Ann Surg, 246, 375-81.
  6. Canadian cancer society's advisory committee on cancer statistics 2013, Canadian cancer statistics 2013 Toronto, Canadian cancer society.
  7. Chen AY, Jemal A, Ward EM (2009). Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer, 115, 3801-7.
  8. Cossu A, Budroni M, Paliogiannis P, et al (2013). Epidemiology of thyroid cancer in an area of epidemic thyroid goiter. J Cancer Epidemiol, 2013, 584768.
  9. Dal ML, Bosetti C, La VC, Franceschi S (2009). Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control, 20, 75-86.
  10. Davies L, Welch HG (2010). Thyroid cancer survival in the United States: observational data from 1973 to 2005. Arch Otolaryngol Head Neck Surg, 136, 440-4.
  11. Dinets A, Hulchiy M, Sofiadis A, et al (2012). Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-chornobyl papillary thyroid carcinoma. Eur J Endocrinol, 166, 1049-60.
  12. Du Y, Han LY, Li DD, et al (2013). Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis. Asian Pac J Cancer Prev, 14, 5483-7.
  13. El-Basmy A, Al-Mohannadi S, Al-Awadi A (2012). Some epidemiological measures of cancer in Kuwait: national cancer registry data from 2000-2009. Asian Pac J Cancer Prev, 13, 3113-8.
  14. Eser S, Yakut C, Ozdemir R, et al (2010). Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev, 11, 1731-9.
  15. Ferlay J, Shin HR, Bray F, et al (2013). Globocan 2008: cancer incidence and mortality worldwide: IARC cancerbase No. 10. Lyon, International Agency for Research on Cancer, 2010.
  16. Fritz AG (2000). International classification of diseases for oncology: ICD-O World Health Organization.
  17. Grodski S, Brown T, Sidhu S, et al (2008). Increasing incidence of thyroid cancer is due to increased pathologic detection. Surg, 144, 1038-43.
  18. Guay, B., Johnson-Obaseki, S., McDonald, J.T., Connell, C., & Corsten, M. (2014). Incidence of differentiated thyroid cancer by socioeconomic status and urban residence: Canada 1991-2006. Thyroid, 24, 552-555.
  19. Ito Y, Miyauchi A, Kihara M, et al (2014). Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid, 24, 27-34.
  20. Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA (2007). Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ, 177, 1357-61.
  21. Kilfoy BA, Zheng T, Holford TR, et al (2009). International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control, 20, 525-31.
  22. Kutikhin AG, Yuzhalin AE, Brailovskiy VV, et al (2012). Analysis of cancer incidence and mortality in the industrial region of South-East Siberia from 1991 through 2010. Asian Pac.J Cancer Prev, 13, 5189-93.
  23. LiVolsi VA (2011). Papillary thyroid carcinoma: an update. Mod Pathol, 24, 1-9.
  24. Malone, MK, Zagzag, J, Ogilvie, JB, Patel, KN, & Heller, KS (2014). Thyroid cancers detected by imaging are not necessarily small or early stage. Thyroid, 24, 314-8.
  25. McLeod DS (2010). Current concepts and future directions in differentiated thyroid cancer. Clin Biochem Rev, 31, 9-19.
  26. McNally RJ, Blakey K, James PW, et al (2012). Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis. Eur J Epidemiol, 27, 615-22.
  27. Minelli G, Conti S, Manno V, Olivieri A, Ascoli V (2013). The geographical pattern of thyroid cancer mortality between 1980 and 2009 in Italy. Thyroid, 23, 1609-18.
  28. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in Tehran metropolis: the first report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med, 12, 15-23.
  29. Netea-Maier RT, Aben KK, Casparie MK, et al (2008). Trends in incidence and mortality of thyroid carcinoma in The Netherlands between 1989 and 2003: correlation with thyroid fine-needle aspiration cytology and thyroid surgery. Int J Cancer, 123, 1681-4.
  30. Olaleye O, Ekrikpo U, Moorthy R, et al (2011). Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006. Eur Arch Otorhinolaryngol, 268, 899-906.
  31. Patel KN, Shaha AR (2006). Poorly differentiated and anaplastic thyroid cancer. Cancer Control, 13, 119-28.
  32. Pathak KA, Leslie WD, Klonisch TC, Nason RW (2013). The changing face of thyroid cancer in a population-based cohort. Cancer Med, 2, 537-44.
  33. Reitzel LR, Nguyen N, Li N, et al (2014). Trends in thyroid cancer incidence in Texas from 1995 to 2008 by socioeconomic status and race/ethnicity. Thyroid, 24, 556-67.
  34. Roche LM, Niu X, Pawlish KS, Henry KA (2011). Thyroid cancer incidence in New Jersey: time trend, birth cohort and socioeconomic status analysis (1979-2006). J Environ Public Health, 2011, 850105.
  35. Siu S, McDonald JT, Rajaraman M, et al (2014). Is lower socioeconomic status associated with more advanced thyroid cancer stage at presentation? a study in two Canadian centers. Thyroid, 24, 545-51.
  36. Sprague BL, Warren AS, Trentham-Dietz A (2008). Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control, 19, 585-93.
  37. Sriplung H, Sontipong S, Martin N, et al (2005). Cancer incidence in Thailand, 1995-1997. Asian Pac J Cancer Prev, 6, 276-81.
  38. Sungwalee W, Vatanasapt P, Kamsa-Ard S, Suwanrungruang K, Promthet S (2013). Reproductive risk factors for thyroid cancer: a prospective cohort study in Khon Kaen, Thailand. Asian Pac J Cancer Prev, 14, 5153-5.
  39. Udelsman R, Zhang Y (2014). The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid, 24, 472-9.
  40. Veiga LH, Neta G, Aschebrook-Kilfoy B, Ron E, Devesa SS (2013). Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008. Thyroid, 23, 748-57.
  41. Wartofsky L (2010). Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones, 9, 103-8.
  42. Aschebrook-Kilfoy B, Grogan RH, Ward MH, Kaplan E, Devesa SS (2013). Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Thyroid, 23, 1015-21.

Cited by

  1. Analysis of Cancer Incidence and Mortality in Iran Using Joinpoint Regression Analysis vol.19, pp.3, 2016,
  2. Hypermetabolic Thyroid Incidentaloma on Positron Emission Tomography: Review of Laboratory, Radiologic, and Pathologic Characteristics vol.2017, pp.2042-0072, 2017,
  3. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers? vol.57, pp.3, 2017,
  4. Thyroid Cancer Epidemiology in South Spain: a population-based time trend study vol.62, pp.2, 2018,